📊 TKNO Key Takeaways
Is Alpha Teknova, Inc. (TKNO) a Good Investment?
Alpha Teknova demonstrates exceptional revenue growth of 5807% YoY, but faces critical profitability and cash flow challenges with a -41.9% operating margin and -9.8M in negative free cash flow. Despite a strong balance sheet and reasonable gross margins, the company is burning cash at an unsustainable rate with only 5.9M in reserves, creating significant risk if growth decelerates or capital access becomes constrained.
Why Buy Alpha Teknova, Inc. Stock? TKNO Key Strengths
- Exceptional revenue growth of 5807% YoY indicating strong market demand or major customer acquisition
- Healthy gross margin of 33.2% demonstrating viable core product economics
- Strong balance sheet with 68.8M stockholders equity and conservative 0.19x debt-to-equity ratio
- Excellent short-term liquidity with 4.58x current ratio reducing near-term solvency risk
- Improving net loss trajectory with 35.5% YoY improvement showing potential operational leverage
TKNO Stock Risks: Alpha Teknova, Inc. Investment Risks
- Severe operating losses of -17M (-41.9% margin) with no visible path to profitability
- Negative operating cash flow of -8.6M indicates the business model is not generating cash even before capital expenditures
- Critical cash runway risk: -9.8M annual free cash flow burn against only 5.9M cash balance creates sub-one-year liquidity runway
- Unexplained 5807% revenue growth suggests potential one-time acquisition or customer concentration risk rather than sustainable organic growth
- Operating expenses scaling faster than gross profit, indicating failure to achieve operating leverage despite massive revenue growth
Key Metrics to Watch
- Operating cash flow trend and timeline to cash flow breakeven (currently -8.6M)
- Operating margin improvement pathway and gross profit to operating expense ratio
- Cash balance and monthly burn rate given current runway of less than 12 months
- Revenue growth sustainability and operating expense discipline in next two quarters
Alpha Teknova, Inc. (TKNO) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.58x current ratio provides a solid financial cushion.
TKNO Profit Margin, ROE & Profitability Analysis
TKNO vs Healthcare Sector: How Alpha Teknova, Inc. Compares
How Alpha Teknova, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Alpha Teknova, Inc. Stock Overvalued? TKNO Valuation Analysis 2026
Based on fundamental analysis, Alpha Teknova, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Alpha Teknova, Inc. Balance Sheet: TKNO Debt, Cash & Liquidity
TKNO Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Alpha Teknova, Inc.'s revenue has shown modest growth of 10% over the 5-year period. The most recent EPS of $-0.57 indicates the company is currently unprofitable.
TKNO Revenue Growth, EPS Growth & YoY Performance
TKNO Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $9.6M | -$4.3M | $-0.08 |
| Q2 2025 | $9.6M | -$3.6M | $-0.07 |
| Q1 2025 | $9.3M | -$4.6M | $-0.09 |
| Q3 2024 | $8.2M | -$7.6M | $-0.15 |
| Q2 2024 | $9.6M | -$5.4M | $-0.13 |
| Q1 2024 | $9.1M | -$8.1M | $-0.20 |
| Q3 2023 | $8.2M | -$10.2M | $-0.34 |
| Q2 2023 | $11.5M | -$6.2M | $-0.22 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Alpha Teknova, Inc. Dividends, Buybacks & Capital Allocation
TKNO SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Alpha Teknova, Inc. (CIK: 0001850902)
📋 Recent SEC Filings
❓ Frequently Asked Questions about TKNO
What is the AI rating for TKNO?
Alpha Teknova, Inc. (TKNO) has an AI rating of SELL with 60% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TKNO's key strengths?
Claude: Exceptional revenue growth of 5807% YoY indicating strong market demand or major customer acquisition. Healthy gross margin of 33.2% demonstrating viable core product economics.
What are the risks of investing in TKNO?
Claude: Severe operating losses of -17M (-41.9% margin) with no visible path to profitability. Negative operating cash flow of -8.6M indicates the business model is not generating cash even before capital expenditures.
What is TKNO's revenue and growth?
Alpha Teknova, Inc. reported revenue of $40.5M.
Does TKNO pay dividends?
Alpha Teknova, Inc. does not currently pay dividends.
Where can I find TKNO SEC filings?
Official SEC filings for Alpha Teknova, Inc. (CIK: 0001850902) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TKNO's EPS?
Alpha Teknova, Inc. has a diluted EPS of $-0.32.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is TKNO a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Alpha Teknova, Inc. has a SELL rating with 60% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is TKNO stock overvalued or undervalued?
Valuation metrics for TKNO: ROE of -25.1% (sector avg: 15%), net margin of -42.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy TKNO stock in 2026?
Our dual AI analysis gives Alpha Teknova, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TKNO's free cash flow?
Alpha Teknova, Inc.'s operating cash flow is $-8.6M, with capital expenditures of $1.1M. FCF margin is -24.2%.
How does TKNO compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -42.6% (avg: 12%), ROE -25.1% (avg: 15%), current ratio 4.58 (avg: 2).